Diego Castillo Villegas

6PUBLICATIONS
28CO-AUTHORS
Pacific Peoples theory of change models for healthAllergyEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial.

Guadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt

|Apr 27, 2024
Levels of Lysozyme and SLPI in Bronchoalveolar Lavage: Exploring Their Role in Interstitial Lung Disease.

Rubén Osuna-Gómez, Maria Mulet, Silvia Barril

|Feb 27, 2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study.

Esteban Cano-Jiménez, Ana Villar Gómez, Eduardo Velez Segovia

|Feb 25, 2023
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study.

Miriana d'Alessandro, Sara Gangi, Piera Soccio

|Jan 21, 2022
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach.

Edoardo Conticini, Miriana d'Alessandro, Laura Bergantini

|Nov 27, 2021
Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19.

Leticia Alserawan, Patricia Peñacoba, Sandra Elizabet Orozco Echevarría

Pageof 1